Press Releases

BOC Sciences Reports Its Antibody Modification and Conjugation Technologies in Detail

The chief technician of BOC Sciences ADC development center recently reported some detailed information regarding its antibody modification and conjugation technologies, bringing the audience and customers a better understanding of how BOC Sciences has contributed to the ADC industry.

BOC Sciences Declares the Availability of 10,000 Impurities, All in Stock!

BOC Sciences recently confirmed to its customers that over 10,000 impurities are now in stock, ready for immediate delivery.

MicrobioSeq Announces the Launch of the Phage Whole-Genome Sequencing Service

CD Genomics RNA-Solutions Platform Now Provides Whole Transcriptome Sequencing Service

CD Formulation Plays a Role in Developing Drug Delivery Systems

Alfa Chemistry Announces the Release of Extracted Peptides

Applications of Liposomal Drug Delivery System Technology

As Paradigm Clinical Research Expands, So Does the Executive Team

Paradigm Clinical Research (Paradigm), with three dedicated research sites in California and Colorado, announced it has grown its executive leadership team, bringing on board Travis Milnes as chief financial officer (CFO) and Amy Henderson as head of clinical operations.

Q² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration with Tasso

Q2 Solutions, a wholly owned subsidiary of IQVIA and a leading global clinical trial laboratory services organization, today announced the launch of the first self-collection safety lab panel for U.S. clinical trial participants by a leading global clinical trial laboratory.

Genezen delivers next phase of cGMP lentiviral and retroviral vector production facility expansion

Genezen has completed another expansion phase at its viral vector process development and cGMP vector production facility in Fishers, Indiana (US).

Paradigm Clinical Research Names Industry Veteran Kurt Mussina as CEO as Expansion Plans Are Set in Motion

Paradigm Clinical Research names clinical research industry leader Kurt Mussina as CEO.

Quotient Sciences Expands UK Facilities to Support the Delivery of Translational Pharmaceutics® Programs

Company increases laboratory and clinical capacity to meet demand for fully integrated drug development capabilities

LILLY RECEIVES MHRA MARKETING AUTHORISATION FOR BARICITINIB (OLUMIANT®) FOR THE TREATMENT OF SEVERE ALOPECIA AREATA (AA) IN ADULT PATIENTS

Biotium’s New Laser Diode Gel Illuminator Offers a Superior Alternative to LED and UV-based Illumination

Biotium has announced the release of the next-generation Gel-Bright™ Laser Diode Gel Illuminator, offering a better alternative to UV and LED-based gel imaging.

dMed | Clinipace announce corporate name change to Caidya

dMed |Clinipace, the established clinical research organization serving global innovators, such as biotechs, announced today that it is changing its corporate name to Caidya

BioIVT Announces Global eCommerce Collaboration With Charles River Laboratories Avian Vaccine Services

Charles River Avian products, which are used for virus research and to produce veterinary and human vaccines, are now available through the BioIVT Digital Portal.

Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022

Biopharma PEG Offers GMP & Non-GMP Grade PEG Derivatives Manufacture Services

Huateng Pharma Develops Sitagliptin & Linagliptin Anti-diabetic Intermediates

Emmes Acquires Clinical Edge

In latest news story from Emmes (CRO) announcing the acquisition of Clinical Edge, which trains and certifies visual function examiners at investigator sites conducting Phase I to IV ophthalmic clinical trials. OptymEdge - The combination of Optym, Emmes' ophthalmology certification unit, and Clinical Edge will make the organization a leader in ophthalmic certification and training services.